4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Grand Pharmaceutical Group Limited (0512) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 12,326 employees. Its market capitalization is roughly HK$17 billion. In the fiscal year ended 2025-12-31, 0512 reported HK$12.3B in revenue and HK$1.2B in net income.
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
Interactive charts & full statements → Open the 0512 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$12.3B | HK$11.6B | HK$10.5B | HK$9.6B | — |
| Gross Profit | HK$6.8B | HK$6.7B | HK$6.5B | HK$6.0B | — |
| Operating Income (EBIT) | HK$1.7B | HK$2.2B | HK$2.8B | HK$2.7B | — |
| Net Income | HK$1.2B | HK$2.5B | HK$1.9B | HK$2.1B | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (HK$910M) | (HK$910M) | (HK$497M) | (HK$390M) | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$27.2B | HK$25.0B | HK$22.5B | HK$22.4B | — |
| Total Liabilities | HK$10.0B | HK$8.5B | HK$7.2B | HK$8.2B | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0512 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms